Synvitrobio, Inc.
San Leandro, US · Delaware corporation · 1 known investors
Healthtech
Founders & leadership
MN
Michael NemzekExecutive Officer, Director
ZS
Zachary SunExecutive Officer, Director
CC
Corinna ChenDirector
FD
Francisco DopazoDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$17.6MraisedSep 2023 · 16 investors · Other Health CareRule 506(b)
▶$17.6MraisedSep 2023 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael NemzekExecutive Officer, Director
- Francisco DopazoDirector
- Zachary SunExecutive Officer, Director
- Corinna ChenDirector
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. ArmyArmy | Phase IISTTR | 2020 | $1000K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $252.1K |
| Department of Energy | Phase I | 2019 | $200K |
| U.S. ArmyArmy | Phase ISTTR | 2019 | $150K |
| National Science Foundation | Phase IISTTR | 2018 | $750K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $276K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
| U.S. ArmyArmy | Phase ISTTR | 2017 | $150K |
| National Science Foundation | Phase ISTTR | 2016 | $225K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.